Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis

Maurer, 2013, Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria, N Engl J Med, 368, 924, 10.1056/NEJMoa1215372

Metz, 2012, Omalizumab in chronic urticaria, Curr Opin Allergy Clin Immunol, 12, 406, 10.1097/ACI.0b013e328355365a

Kaplan, 2013, Omalizumab in chronicidiopathic/spontaneous urticaria patients symptomatic despite standard combination therapy, J Allergy Clin Immunol, 132, 101, 10.1016/j.jaci.2013.05.013

Maurer, 2011, Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report, Allergy, 66, 317, 10.1111/j.1398-9995.2010.02496.x

Mlynek, 2009, The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings, Allergy, 64, 927, 10.1111/j.1398-9995.2008.01920.x

Zuberbier, 2009, EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria, Allergy, 64, 1427, 10.1111/j.1398-9995.2009.02178.x

Holgate, 2005, Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy, Clin Exp Allergy, 35, 408, 10.1111/j.1365-2222.2005.02191.x

Slavin, 2009, Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations, J Allergy Clin Immunol, 123, 10.1016/j.jaci.2008.09.050

Verbruggen, 2009, Anti-IgE for the treatment of allergic rhinitis—and eventually nasal polyps?, Int Arch Allergy Immunol, 148, 87, 10.1159/000155739

Boyce, 2006, Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE, J Allergy Clin Immunol, 117, 1415, 10.1016/j.jaci.2006.04.003

Metz, 2008, Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy, Allergy, 63, 247, 10.1111/j.1398-9995.2007.01591.x

Guzelbey, 2008, Successful treatment of solar urticaria with anti-immunoglobulin E therapy, Allergy, 63, 1563, 10.1111/j.1398-9995.2008.01879.x

Godse, 2008, Omalizumab in severe chronic urticaria, Indian J Dermatol Venereol Leprol, 74, 157, 10.4103/0378-6323.39708

Spector, 2007, Effect of omalizumab on patients with chronic urticaria, Ann Allergy Asthma Immunol, 99, 190, 10.1016/S1081-1206(10)60644-8

Gober, 2008, Effect of anti-IgE (Omalizumab) in chronic idiopathic urticaria (CIU) patients, J Allergy Clin Immunol, 121, S147, 10.1016/j.jaci.2007.12.1121

Kaplan, 2008, Treatment of chronic autoimmune urticaria with omalizumab, J Allergy Clin Immunol, 122, 569, 10.1016/j.jaci.2008.07.006

Ivyanskiy, 2012, Omalizumab for chronic urticaria: a case series and overview of the literature, Case Rep Dermatol, 4, 19, 10.1159/000336205

Nam, 2012, Effects of omalizumab treatment in patients with refractory chronic urticaria, Allergy Asthma Immunol Res, 4, 357, 10.4168/aair.2012.4.6.357

Song, 2013, Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria, Ann Allergy Asthma Immunol, 110, 113, 10.1016/j.anai.2012.11.022

Lefevre, 2013, A long term case series study of the effect of omalizumab on chronic spontaneous urticaria, Ann Dermatol, 25, 242, 10.5021/ad.2013.25.2.242

Pressler, 2013, Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio-oedema, Clin Exp Dermatol, 38, 151, 10.1111/j.1365-2230.2012.04430.x

Maurer, 2011, Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase, J Allergy Clin Immunol, 128, 10.1016/j.jaci.2011.04.038

Saini, 2011, A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria, J Allergy Clin Immunol, 128, 10.1016/j.jaci.2011.06.010

Zuberbier, 2009, EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria, Allergy, 64, 1417, 10.1111/j.1398-9995.2009.02179.x

Magerl, 2009, The definition and diagnostic testing of physical and cholinergic urticarias—EAACI/GA2LEN/EDF/UNEV consensus panel recommendations, Allergy, 64, 1715, 10.1111/j.1398-9995.2009.02177.x

Mlynek, 2013, A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism, Clin Exp Dermatol, 38, 360, 10.1111/ced.12107

Magerl, 2012, Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H(1)-antihistamine dose escalation, Br J Dermatol, 166, 1095, 10.1111/j.1365-2133.2012.10822.x

Sabroe, 1999, The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria, Br J Dermatol, 140, 446, 10.1046/j.1365-2133.1999.02707.x

Blunk, 2004, Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin, Anesth Analg, 98, 364, 10.1213/01.ANE.0000097168.32472.0D

Hochhaus, 2003, Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma, Curr Med Res Opin, 19, 491, 10.1185/030079903125002171

Ferrer, 2011, Omalizumab is effective in nonautoimmune urticaria, J Allergy Clin Immunol, 127, 1300, 10.1016/j.jaci.2010.12.1085